| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 219 | 2024 | 11726 | 7.580 |
Why?
|
| Insulin Resistance | 84 | 2023 | 3864 | 4.420 |
Why?
|
| Blood Glucose | 104 | 2023 | 6254 | 4.000 |
Why?
|
| Fasting | 47 | 2022 | 1592 | 3.370 |
Why?
|
| Insulin | 74 | 2023 | 6582 | 3.020 |
Why?
|
| Polymorphism, Single Nucleotide | 119 | 2023 | 15520 | 2.840 |
Why?
|
| Diabetes Mellitus | 56 | 2023 | 5749 | 2.330 |
Why?
|
| Genome-Wide Association Study | 88 | 2024 | 12262 | 2.130 |
Why?
|
| Cardiovascular Diseases | 86 | 2023 | 15160 | 1.990 |
Why?
|
| Adiponectin | 24 | 2019 | 1101 | 1.860 |
Why?
|
| Genetic Variation | 46 | 2022 | 6542 | 1.720 |
Why?
|
| Obesity | 72 | 2023 | 12746 | 1.650 |
Why?
|
| Genetic Predisposition to Disease | 75 | 2024 | 17446 | 1.570 |
Why?
|
| Genotype | 53 | 2023 | 12952 | 1.480 |
Why?
|
| Diabetic Angiopathies | 13 | 2020 | 818 | 1.460 |
Why?
|
| Body Mass Index | 75 | 2023 | 12721 | 1.370 |
Why?
|
| Hyperglycemia | 21 | 2023 | 1373 | 1.310 |
Why?
|
| Quantitative Trait Loci | 24 | 2021 | 2019 | 1.290 |
Why?
|
| Albuminuria | 20 | 2013 | 681 | 1.260 |
Why?
|
| Risk Factors | 189 | 2024 | 72296 | 1.240 |
Why?
|
| Resistin | 10 | 2012 | 170 | 1.170 |
Why?
|
| Middle Aged | 318 | 2023 | 213390 | 1.170 |
Why?
|
| Prediabetic State | 11 | 2023 | 499 | 1.140 |
Why?
|
| Glucose Intolerance | 15 | 2023 | 577 | 1.140 |
Why?
|
| Male | 340 | 2023 | 350115 | 0.980 |
Why?
|
| Female | 366 | 2023 | 380193 | 0.970 |
Why?
|
| Humans | 508 | 2024 | 744366 | 0.950 |
Why?
|
| Quantitative Trait, Heritable | 10 | 2021 | 544 | 0.940 |
Why?
|
| Adult | 223 | 2024 | 214052 | 0.840 |
Why?
|
| Intra-Abdominal Fat | 10 | 2014 | 591 | 0.840 |
Why?
|
| Genome, Human | 18 | 2021 | 4420 | 0.840 |
Why?
|
| Coronary Disease | 22 | 2023 | 6077 | 0.820 |
Why?
|
| Aged | 185 | 2022 | 163288 | 0.820 |
Why?
|
| Genetic Loci | 19 | 2022 | 2575 | 0.770 |
Why?
|
| Glucose | 17 | 2023 | 4398 | 0.750 |
Why?
|
| Relief Work | 1 | 2022 | 137 | 0.730 |
Why?
|
| Gene Frequency | 23 | 2019 | 3587 | 0.710 |
Why?
|
| Metabolomics | 3 | 2022 | 1485 | 0.710 |
Why?
|
| Cholesterol, HDL | 19 | 2021 | 1813 | 0.700 |
Why?
|
| Coronary Artery Disease | 17 | 2024 | 6486 | 0.700 |
Why?
|
| Insulin, Long-Acting | 3 | 2014 | 57 | 0.700 |
Why?
|
| Hypoglycemic Agents | 17 | 2020 | 2873 | 0.700 |
Why?
|
| Proinsulin | 6 | 2023 | 133 | 0.690 |
Why?
|
| Hypertension | 35 | 2020 | 8479 | 0.670 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 8 | 2016 | 281 | 0.650 |
Why?
|
| Primary Health Care | 12 | 2022 | 4557 | 0.640 |
Why?
|
| Phenotype | 40 | 2022 | 16367 | 0.640 |
Why?
|
| Incidence | 58 | 2020 | 20952 | 0.640 |
Why?
|
| Diabetes Complications | 10 | 2020 | 1359 | 0.640 |
Why?
|
| Massachusetts | 39 | 2014 | 8662 | 0.640 |
Why?
|
| Patient Compliance | 14 | 2009 | 2684 | 0.630 |
Why?
|
| Cohort Studies | 89 | 2021 | 40559 | 0.630 |
Why?
|
| Weight Gain | 6 | 2013 | 2293 | 0.620 |
Why?
|
| Glucose Tolerance Test | 22 | 2023 | 1151 | 0.610 |
Why?
|
| Genetic Association Studies | 12 | 2022 | 2703 | 0.590 |
Why?
|
| Insulin Receptor Substrate Proteins | 3 | 2021 | 563 | 0.580 |
Why?
|
| Insulin-Secreting Cells | 7 | 2020 | 892 | 0.580 |
Why?
|
| Triglycerides | 22 | 2021 | 2453 | 0.570 |
Why?
|
| Diet | 24 | 2023 | 7937 | 0.570 |
Why?
|
| Polymorphism, Genetic | 15 | 2022 | 4328 | 0.530 |
Why?
|
| Adipose Tissue | 8 | 2019 | 3280 | 0.520 |
Why?
|
| Acculturation | 1 | 2016 | 182 | 0.520 |
Why?
|
| Heart Diseases | 11 | 2014 | 2789 | 0.510 |
Why?
|
| Models, Genetic | 11 | 2022 | 3493 | 0.500 |
Why?
|
| Refugees | 1 | 2022 | 511 | 0.490 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2014 | 34 | 0.490 |
Why?
|
| Atherosclerosis | 6 | 2023 | 3444 | 0.490 |
Why?
|
| Prevalence | 36 | 2022 | 15221 | 0.490 |
Why?
|
| Genetic Counseling | 4 | 2012 | 600 | 0.490 |
Why?
|
| Alleles | 26 | 2022 | 6933 | 0.490 |
Why?
|
| C-Reactive Protein | 20 | 2022 | 3778 | 0.490 |
Why?
|
| Multifactorial Inheritance | 7 | 2024 | 1195 | 0.480 |
Why?
|
| Chromosome Mapping | 12 | 2018 | 4740 | 0.480 |
Why?
|
| Hyperinsulinism | 6 | 2015 | 415 | 0.470 |
Why?
|
| Life Style | 19 | 2022 | 3835 | 0.460 |
Why?
|
| Health Literacy | 2 | 2016 | 414 | 0.460 |
Why?
|
| Meta-Analysis as Topic | 14 | 2021 | 1342 | 0.460 |
Why?
|
| Subcutaneous Fat | 4 | 2013 | 391 | 0.460 |
Why?
|
| Adiposity | 9 | 2020 | 1806 | 0.460 |
Why?
|
| Outpatient Clinics, Hospital | 3 | 2004 | 392 | 0.450 |
Why?
|
| Mendelian Randomization Analysis | 8 | 2022 | 967 | 0.450 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2014 | 417 | 0.450 |
Why?
|
| Dyslipidemias | 6 | 2021 | 849 | 0.450 |
Why?
|
| American Heart Association | 9 | 2010 | 1057 | 0.450 |
Why?
|
| Smoking Cessation | 3 | 2016 | 2071 | 0.440 |
Why?
|
| Genetic Linkage | 5 | 2008 | 2421 | 0.440 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2018 | 4424 | 0.440 |
Why?
|
| Aging | 14 | 2022 | 8664 | 0.430 |
Why?
|
| Aged, 80 and over | 54 | 2022 | 57776 | 0.430 |
Why?
|
| Longitudinal Studies | 32 | 2022 | 13991 | 0.430 |
Why?
|
| Disease Management | 4 | 2020 | 2460 | 0.420 |
Why?
|
| Odds Ratio | 29 | 2020 | 9849 | 0.420 |
Why?
|
| Lipids | 14 | 2021 | 3307 | 0.410 |
Why?
|
| Cross-Sectional Studies | 55 | 2022 | 25039 | 0.410 |
Why?
|
| Prospective Studies | 50 | 2023 | 53290 | 0.400 |
Why?
|
| Choristoma | 1 | 2013 | 214 | 0.400 |
Why?
|
| Genetic Testing | 6 | 2012 | 3444 | 0.390 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2016 | 2016 | 0.390 |
Why?
|
| Risk Assessment | 23 | 2021 | 23336 | 0.380 |
Why?
|
| Case-Control Studies | 38 | 2022 | 21748 | 0.370 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 581 | 0.370 |
Why?
|
| Prostatic Hyperplasia | 5 | 2002 | 523 | 0.360 |
Why?
|
| Hypoglycemia | 2 | 2015 | 861 | 0.360 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2011 | 143 | 0.360 |
Why?
|
| United States | 70 | 2024 | 69872 | 0.360 |
Why?
|
| Sweetening Agents | 4 | 2017 | 296 | 0.360 |
Why?
|
| Interleukin-6 | 10 | 2022 | 3203 | 0.350 |
Why?
|
| Follow-Up Studies | 37 | 2018 | 39052 | 0.340 |
Why?
|
| Proportional Hazards Models | 25 | 2019 | 12356 | 0.340 |
Why?
|
| Predictive Value of Tests | 19 | 2021 | 15078 | 0.340 |
Why?
|
| Nutrition Surveys | 11 | 2022 | 1660 | 0.340 |
Why?
|
| Vitamin D | 5 | 2018 | 3224 | 0.330 |
Why?
|
| Blood Pressure | 22 | 2018 | 8551 | 0.330 |
Why?
|
| Magnesium | 4 | 2013 | 813 | 0.320 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 3 | 2009 | 357 | 0.320 |
Why?
|
| Attitude to Health | 2 | 2009 | 2052 | 0.320 |
Why?
|
| Logistic Models | 27 | 2020 | 13409 | 0.320 |
Why?
|
| Inflammation | 19 | 2014 | 10637 | 0.320 |
Why?
|
| Electronic Health Records | 5 | 2020 | 4468 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2008 | 658 | 0.310 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 7 | 2013 | 154 | 0.310 |
Why?
|
| Evidence-Based Medicine | 6 | 2023 | 3611 | 0.310 |
Why?
|
| Sex Factors | 27 | 2021 | 10400 | 0.300 |
Why?
|
| Creatinine | 11 | 2012 | 1919 | 0.300 |
Why?
|
| Vitamin D Deficiency | 2 | 2018 | 1343 | 0.300 |
Why?
|
| Stroke | 15 | 2021 | 9981 | 0.300 |
Why?
|
| Linkage Disequilibrium | 11 | 2018 | 1997 | 0.300 |
Why?
|
| Physicians, Family | 1 | 2009 | 345 | 0.300 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2021 | 315 | 0.300 |
Why?
|
| Health Behavior | 7 | 2012 | 2635 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2008 | 367 | 0.290 |
Why?
|
| E-Selectin | 4 | 2005 | 579 | 0.290 |
Why?
|
| Postprandial Period | 2 | 2006 | 292 | 0.290 |
Why?
|
| Risk | 20 | 2020 | 9688 | 0.290 |
Why?
|
| Multivariate Analysis | 30 | 2018 | 12244 | 0.290 |
Why?
|
| Waist-Hip Ratio | 7 | 2021 | 517 | 0.290 |
Why?
|
| Genomic Imprinting | 3 | 2020 | 328 | 0.290 |
Why?
|
| Linear Models | 16 | 2017 | 5953 | 0.280 |
Why?
|
| Social Support | 1 | 2016 | 2118 | 0.280 |
Why?
|
| Socioeconomic Factors | 13 | 2022 | 7785 | 0.270 |
Why?
|
| Feeding Behavior | 11 | 2017 | 3188 | 0.270 |
Why?
|
| Cholesterol, LDL | 13 | 2022 | 2355 | 0.270 |
Why?
|
| Diabetes, Gestational | 3 | 2023 | 1184 | 0.270 |
Why?
|
| Oxidative Stress | 5 | 2014 | 3084 | 0.270 |
Why?
|
| Genetic Heterogeneity | 2 | 2010 | 733 | 0.270 |
Why?
|
| Documentation | 2 | 2009 | 871 | 0.260 |
Why?
|
| Dietary Fats | 5 | 2019 | 2016 | 0.260 |
Why?
|
| Age Factors | 21 | 2017 | 18373 | 0.260 |
Why?
|
| Sarcopenia | 2 | 2022 | 368 | 0.260 |
Why?
|
| Yogurt | 3 | 2017 | 72 | 0.260 |
Why?
|
| Islets of Langerhans | 5 | 2024 | 1352 | 0.260 |
Why?
|
| Food Supply | 4 | 2018 | 524 | 0.260 |
Why?
|
| Population Groups | 2 | 2019 | 209 | 0.260 |
Why?
|
| TCF Transcription Factors | 4 | 2010 | 140 | 0.250 |
Why?
|
| Body Size | 5 | 2020 | 461 | 0.250 |
Why?
|
| Endothelium, Vascular | 8 | 2012 | 4459 | 0.250 |
Why?
|
| Body Composition | 7 | 2022 | 2402 | 0.240 |
Why?
|
| Adipokines | 3 | 2017 | 320 | 0.240 |
Why?
|
| Aorta, Abdominal | 3 | 2013 | 646 | 0.240 |
Why?
|
| Hemostasis | 4 | 2012 | 458 | 0.240 |
Why?
|
| HIV Infections | 15 | 2022 | 16715 | 0.240 |
Why?
|
| Lod Score | 4 | 2008 | 614 | 0.240 |
Why?
|
| Health Surveys | 11 | 2021 | 4036 | 0.240 |
Why?
|
| Minisatellite Repeats | 1 | 2004 | 165 | 0.240 |
Why?
|
| Beverages | 3 | 2017 | 821 | 0.230 |
Why?
|
| Body Fat Distribution | 3 | 2022 | 244 | 0.230 |
Why?
|
| Subcutaneous Fat, Abdominal | 3 | 2010 | 93 | 0.230 |
Why?
|
| Information Systems | 1 | 2006 | 410 | 0.230 |
Why?
|
| Outpatients | 3 | 2021 | 1487 | 0.230 |
Why?
|
| Homeostasis | 11 | 2019 | 3339 | 0.230 |
Why?
|
| Cholesterol | 13 | 2017 | 2919 | 0.230 |
Why?
|
| Waist Circumference | 9 | 2015 | 917 | 0.230 |
Why?
|
| Inflammation Mediators | 3 | 2009 | 1888 | 0.220 |
Why?
|
| Family Health | 4 | 2016 | 1281 | 0.220 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2022 | 314 | 0.220 |
Why?
|
| Neoplasms | 7 | 2016 | 21696 | 0.220 |
Why?
|
| Overweight | 9 | 2013 | 2371 | 0.220 |
Why?
|
| Poverty | 6 | 2021 | 2660 | 0.220 |
Why?
|
| Carbonated Beverages | 3 | 2016 | 214 | 0.210 |
Why?
|
| DNA Methylation | 4 | 2023 | 4285 | 0.210 |
Why?
|
| Hypercholesterolemia | 5 | 2010 | 1151 | 0.210 |
Why?
|
| Hyperlipidemias | 8 | 2010 | 789 | 0.210 |
Why?
|
| Receptor, Melatonin, MT2 | 2 | 2015 | 77 | 0.210 |
Why?
|
| Polypharmacy | 1 | 2004 | 294 | 0.210 |
Why?
|
| Sickle Cell Trait | 1 | 2022 | 81 | 0.210 |
Why?
|
| Self Care | 4 | 2008 | 786 | 0.200 |
Why?
|
| Disease Susceptibility | 3 | 2021 | 1782 | 0.200 |
Why?
|
| Metabolic Diseases | 3 | 2008 | 658 | 0.200 |
Why?
|
| Dairy Products | 2 | 2017 | 498 | 0.200 |
Why?
|
| Internet | 2 | 2005 | 3056 | 0.200 |
Why?
|
| Drug Costs | 2 | 2006 | 1105 | 0.200 |
Why?
|
| Leptin | 3 | 2020 | 1600 | 0.200 |
Why?
|
| Smoking | 19 | 2016 | 8987 | 0.200 |
Why?
|
| Antihypertensive Agents | 5 | 2008 | 2047 | 0.200 |
Why?
|
| Alanine Transaminase | 2 | 2022 | 592 | 0.200 |
Why?
|
| Ankle Brachial Index | 2 | 2013 | 154 | 0.200 |
Why?
|
| Cluster Analysis | 4 | 2014 | 2715 | 0.200 |
Why?
|
| Income | 3 | 2020 | 1913 | 0.200 |
Why?
|
| Glucose-6-Phosphatase | 3 | 2016 | 73 | 0.200 |
Why?
|
| Myocardial Infarction | 5 | 2022 | 11718 | 0.200 |
Why?
|
| Homocysteine | 3 | 2012 | 647 | 0.190 |
Why?
|
| Molecular Epidemiology | 3 | 2019 | 468 | 0.190 |
Why?
|
| Microvascular Angina | 1 | 2000 | 15 | 0.190 |
Why?
|
| Genomics | 6 | 2023 | 5717 | 0.190 |
Why?
|
| Kidney Failure, Chronic | 6 | 2012 | 2535 | 0.190 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2022 | 2200 | 0.190 |
Why?
|
| Carbohydrates | 2 | 2016 | 394 | 0.190 |
Why?
|
| Health Status Indicators | 1 | 2006 | 970 | 0.190 |
Why?
|
| Molecular Sequence Annotation | 3 | 2021 | 528 | 0.190 |
Why?
|
| Insurance Claim Review | 1 | 2005 | 720 | 0.190 |
Why?
|
| Educational Status | 5 | 2020 | 2540 | 0.180 |
Why?
|
| Aldosterone | 6 | 2010 | 877 | 0.180 |
Why?
|
| von Willebrand Factor | 3 | 2010 | 669 | 0.180 |
Why?
|
| Obesity, Abdominal | 3 | 2013 | 361 | 0.180 |
Why?
|
| Geriatrics | 2 | 2004 | 397 | 0.180 |
Why?
|
| Apolipoproteins E | 4 | 2005 | 1438 | 0.180 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2022 | 612 | 0.180 |
Why?
|
| Regression Analysis | 15 | 2018 | 6459 | 0.180 |
Why?
|
| Developing Countries | 3 | 2021 | 2815 | 0.180 |
Why?
|
| Area Under Curve | 4 | 2018 | 1655 | 0.170 |
Why?
|
| Prostate-Specific Antigen | 3 | 2001 | 2494 | 0.170 |
Why?
|
| Blood Chemical Analysis | 1 | 2001 | 440 | 0.170 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2017 | 3255 | 0.170 |
Why?
|
| Confidence Intervals | 10 | 2013 | 2971 | 0.170 |
Why?
|
| Quality Indicators, Health Care | 1 | 2009 | 1831 | 0.170 |
Why?
|
| Models, Statistical | 6 | 2021 | 5101 | 0.170 |
Why?
|
| Glycemic Index | 4 | 2015 | 394 | 0.170 |
Why?
|
| Motivation | 5 | 2012 | 1971 | 0.170 |
Why?
|
| Genes, Mitochondrial | 1 | 2018 | 61 | 0.170 |
Why?
|
| Pyrophosphatases | 2 | 2010 | 137 | 0.170 |
Why?
|
| Metabolome | 3 | 2016 | 895 | 0.170 |
Why?
|
| Cell Adhesion Molecules | 2 | 2004 | 1602 | 0.160 |
Why?
|
| Urinary Retention | 1 | 1999 | 111 | 0.160 |
Why?
|
| Natriuretic Peptide, Brain | 4 | 2010 | 1572 | 0.160 |
Why?
|
| Hemoglobin, Sickle | 1 | 2019 | 122 | 0.160 |
Why?
|
| ROC Curve | 5 | 2021 | 3528 | 0.160 |
Why?
|
| Open Reading Frames | 1 | 2021 | 811 | 0.160 |
Why?
|
| Phosphoric Diester Hydrolases | 2 | 2010 | 197 | 0.160 |
Why?
|
| Abdominal Fat | 3 | 2010 | 223 | 0.160 |
Why?
|
| Factor Analysis, Statistical | 5 | 2013 | 977 | 0.160 |
Why?
|
| Mexico | 4 | 2021 | 689 | 0.160 |
Why?
|
| Health Services | 2 | 2016 | 758 | 0.160 |
Why?
|
| Monitoring, Immunologic | 1 | 1998 | 100 | 0.160 |
Why?
|
| Fathers | 1 | 2000 | 358 | 0.160 |
Why?
|
| Health Maintenance Organizations | 5 | 2007 | 642 | 0.160 |
Why?
|
| Pedigree | 7 | 2020 | 4642 | 0.160 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2021 | 504 | 0.150 |
Why?
|
| Taurine | 1 | 2018 | 94 | 0.150 |
Why?
|
| Weight Loss | 7 | 2022 | 2625 | 0.150 |
Why?
|
| Time Factors | 17 | 2018 | 40075 | 0.150 |
Why?
|
| Gene Expression Regulation | 10 | 2019 | 12073 | 0.150 |
Why?
|
| Blood Coagulation Factors | 1 | 2000 | 355 | 0.150 |
Why?
|
| Diet, Mediterranean | 3 | 2009 | 700 | 0.150 |
Why?
|
| Young Adult | 23 | 2022 | 56429 | 0.150 |
Why?
|
| Receptors, Leptin | 2 | 2009 | 361 | 0.150 |
Why?
|
| Metabolism | 1 | 2018 | 196 | 0.150 |
Why?
|
| Glomerular Filtration Rate | 7 | 2010 | 2166 | 0.150 |
Why?
|
| Risk Reduction Behavior | 3 | 2011 | 1125 | 0.150 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2021 | 3020 | 0.150 |
Why?
|
| Pericardium | 2 | 2014 | 667 | 0.150 |
Why?
|
| Severity of Illness Index | 7 | 2021 | 15535 | 0.150 |
Why?
|
| Insurance, Health | 3 | 2010 | 2494 | 0.150 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2022 | 451 | 0.150 |
Why?
|
| Neck | 2 | 2013 | 698 | 0.150 |
Why?
|
| Apolipoprotein B-100 | 2 | 2015 | 148 | 0.140 |
Why?
|
| Hospitalization | 6 | 2022 | 10259 | 0.140 |
Why?
|
| Boston | 8 | 2018 | 9312 | 0.140 |
Why?
|
| Phenylalanine | 1 | 2018 | 365 | 0.140 |
Why?
|
| Physician-Patient Relations | 3 | 2011 | 3229 | 0.140 |
Why?
|
| Computational Biology | 5 | 2021 | 3519 | 0.140 |
Why?
|
| Fatty Liver | 2 | 2014 | 727 | 0.140 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2016 | 93 | 0.140 |
Why?
|
| Diabetic Retinopathy | 4 | 2013 | 1210 | 0.140 |
Why?
|
| Haplotypes | 4 | 2021 | 2779 | 0.140 |
Why?
|
| Patient Selection | 4 | 2009 | 4216 | 0.140 |
Why?
|
| Dietary Sucrose | 3 | 2014 | 246 | 0.130 |
Why?
|
| Body Weight | 9 | 2014 | 4671 | 0.130 |
Why?
|
| Epigenesis, Genetic | 5 | 2023 | 3646 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 67 | 0.130 |
Why?
|
| Fatty Acid-Binding Proteins | 2 | 2016 | 300 | 0.130 |
Why?
|
| Calcinosis | 3 | 2013 | 1499 | 0.130 |
Why?
|
| Reference Values | 9 | 2017 | 4982 | 0.130 |
Why?
|
| Chemokines, CC | 1 | 2016 | 291 | 0.130 |
Why?
|
| Health Facilities | 1 | 2020 | 572 | 0.130 |
Why?
|
| Meat Products | 1 | 2015 | 99 | 0.130 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2019 | 783 | 0.130 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2016 | 1261 | 0.130 |
Why?
|
| Patient Education as Topic | 1 | 2005 | 2278 | 0.130 |
Why?
|
| Disease Progression | 7 | 2024 | 13286 | 0.130 |
Why?
|
| Kidney Diseases | 3 | 2013 | 2148 | 0.130 |
Why?
|
| Genetic Markers | 5 | 2023 | 2634 | 0.130 |
Why?
|
| Health Care Surveys | 2 | 2020 | 2453 | 0.120 |
Why?
|
| Adult Children | 3 | 2013 | 100 | 0.120 |
Why?
|
| Bayes Theorem | 2 | 2022 | 2307 | 0.120 |
Why?
|
| Glycine | 1 | 2018 | 671 | 0.120 |
Why?
|
| Inflammasomes | 1 | 2019 | 495 | 0.120 |
Why?
|
| I-kappa B Kinase | 1 | 2016 | 252 | 0.120 |
Why?
|
| Tryptophan | 2 | 2021 | 478 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2015 | 3921 | 0.120 |
Why?
|
| Health Expenditures | 2 | 2017 | 2349 | 0.120 |
Why?
|
| Least-Squares Analysis | 2 | 2016 | 379 | 0.120 |
Why?
|
| Advisory Committees | 2 | 2009 | 775 | 0.120 |
Why?
|
| Meat | 2 | 2015 | 592 | 0.120 |
Why?
|
| Milk | 2 | 2017 | 450 | 0.120 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2016 | 424 | 0.120 |
Why?
|
| Syntaxin 1 | 1 | 2014 | 30 | 0.120 |
Why?
|
| Metformin | 4 | 2011 | 836 | 0.120 |
Why?
|
| R-SNARE Proteins | 1 | 2014 | 74 | 0.120 |
Why?
|
| Genome | 1 | 2022 | 1807 | 0.120 |
Why?
|
| Guideline Adherence | 3 | 2017 | 2265 | 0.120 |
Why?
|
| Atrial Function | 1 | 2014 | 107 | 0.120 |
Why?
|
| Adolescent | 23 | 2021 | 85779 | 0.120 |
Why?
|
| Monitoring, Physiologic | 2 | 2020 | 1739 | 0.120 |
Why?
|
| Nuclear Family | 2 | 2007 | 318 | 0.110 |
Why?
|
| DNA, Mitochondrial | 1 | 2018 | 817 | 0.110 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 1070 | 0.110 |
Why?
|
| Transcription Factors | 7 | 2023 | 12207 | 0.110 |
Why?
|
| Spouses | 1 | 2016 | 286 | 0.110 |
Why?
|
| Receptors, Gastrointestinal Hormone | 2 | 2010 | 38 | 0.110 |
Why?
|
| Introns | 1 | 2016 | 992 | 0.110 |
Why?
|
| Stress, Psychological | 3 | 2008 | 4245 | 0.110 |
Why?
|
| Flavonols | 1 | 2013 | 83 | 0.110 |
Why?
|
| Health Services Accessibility | 2 | 2020 | 5135 | 0.110 |
Why?
|
| Homozygote | 3 | 2015 | 1787 | 0.110 |
Why?
|
| Quality Assurance, Health Care | 3 | 2011 | 2212 | 0.110 |
Why?
|
| Intensive Care Units | 3 | 2021 | 3680 | 0.110 |
Why?
|
| Nutrition Assessment | 2 | 2014 | 723 | 0.110 |
Why?
|
| Genetic Pleiotropy | 1 | 2014 | 182 | 0.110 |
Why?
|
| Chronic Disease | 4 | 2024 | 9145 | 0.110 |
Why?
|
| Italy | 4 | 2011 | 832 | 0.110 |
Why?
|
| Databases, Genetic | 3 | 2021 | 1783 | 0.110 |
Why?
|
| Nutrition Policy | 2 | 2007 | 488 | 0.110 |
Why?
|
| Receptors, Cell Surface | 2 | 2013 | 2865 | 0.110 |
Why?
|
| Integrin alpha1 | 1 | 2012 | 13 | 0.110 |
Why?
|
| Comorbidity | 9 | 2020 | 10388 | 0.110 |
Why?
|
| Europe | 5 | 2020 | 3338 | 0.110 |
Why?
|
| Prognosis | 12 | 2023 | 29060 | 0.110 |
Why?
|
| Lipoproteins | 3 | 2003 | 878 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2004 | 2531 | 0.110 |
Why?
|
| Body Height | 3 | 2015 | 1578 | 0.110 |
Why?
|
| Apolipoprotein C-I | 1 | 2011 | 7 | 0.100 |
Why?
|
| Food | 1 | 2017 | 772 | 0.100 |
Why?
|
| Hepatitis C | 1 | 2022 | 1591 | 0.100 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2023 | 1519 | 0.100 |
Why?
|
| Emergency Service, Hospital | 2 | 2018 | 7658 | 0.100 |
Why?
|
| Urbanization | 1 | 2012 | 104 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2003 | 287 | 0.100 |
Why?
|
| Heart Failure | 3 | 2013 | 10895 | 0.100 |
Why?
|
| Anorexia Nervosa | 1 | 2021 | 1286 | 0.100 |
Why?
|
| Vitamin K 1 | 2 | 2009 | 48 | 0.100 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 1157 | 0.100 |
Why?
|
| Exercise | 7 | 2012 | 5615 | 0.100 |
Why?
|
| Energy Intake | 8 | 2014 | 2148 | 0.100 |
Why?
|
| Bone Density | 3 | 2014 | 3468 | 0.100 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 265 | 0.100 |
Why?
|
| Fibroblast Growth Factors | 1 | 2017 | 878 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2020 | 3338 | 0.100 |
Why?
|
| Dietary Carbohydrates | 2 | 2009 | 905 | 0.100 |
Why?
|
| High Mobility Group Proteins | 1 | 2012 | 187 | 0.100 |
Why?
|
| Texas | 2 | 2003 | 391 | 0.100 |
Why?
|
| Causality | 4 | 2022 | 1275 | 0.100 |
Why?
|
| Phospholipase C gamma | 1 | 2011 | 128 | 0.100 |
Why?
|
| Epigenomics | 3 | 2024 | 903 | 0.100 |
Why?
|
| PPAR gamma | 2 | 2012 | 493 | 0.100 |
Why?
|
| Trace Elements | 1 | 2013 | 198 | 0.100 |
Why?
|
| Retrospective Studies | 23 | 2023 | 77460 | 0.100 |
Why?
|
| RANK Ligand | 1 | 2013 | 326 | 0.100 |
Why?
|
| Carotid Artery Diseases | 1 | 2017 | 879 | 0.100 |
Why?
|
| Phosphate Transport Proteins | 1 | 2010 | 8 | 0.100 |
Why?
|
| Lipid Metabolism | 2 | 2021 | 1889 | 0.090 |
Why?
|
| Cotinine | 1 | 2011 | 206 | 0.090 |
Why?
|
| Calcium Channels | 1 | 2014 | 622 | 0.090 |
Why?
|
| Laminin | 1 | 2012 | 419 | 0.090 |
Why?
|
| Menopause, Premature | 1 | 1992 | 132 | 0.090 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2010 | 54 | 0.090 |
Why?
|
| Health Care Costs | 2 | 2018 | 3208 | 0.090 |
Why?
|
| Costs and Cost Analysis | 2 | 2006 | 1680 | 0.090 |
Why?
|
| Mothers | 1 | 2000 | 2165 | 0.090 |
Why?
|
| Diabetic Nephropathies | 3 | 2024 | 984 | 0.090 |
Why?
|
| Liver | 5 | 2021 | 7475 | 0.090 |
Why?
|
| Dietary Supplements | 3 | 2013 | 3296 | 0.090 |
Why?
|
| Data Collection | 4 | 2010 | 3339 | 0.090 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 4 | 2005 | 707 | 0.090 |
Why?
|
| Endpoint Determination | 1 | 2013 | 601 | 0.090 |
Why?
|
| Antipsychotic Agents | 1 | 2023 | 3057 | 0.090 |
Why?
|
| Factor VII | 1 | 2010 | 139 | 0.090 |
Why?
|
| Lipodystrophy | 2 | 2001 | 147 | 0.090 |
Why?
|
| Speech Recognition Software | 1 | 2010 | 72 | 0.090 |
Why?
|
| Age of Onset | 4 | 2013 | 3270 | 0.090 |
Why?
|
| Atrial Function, Left | 1 | 2011 | 173 | 0.090 |
Why?
|
| Calcification, Physiologic | 1 | 2010 | 169 | 0.090 |
Why?
|
| Sex Characteristics | 7 | 2021 | 2585 | 0.090 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 1968 | 0.090 |
Why?
|
| Anthropometry | 4 | 2018 | 1350 | 0.090 |
Why?
|
| Alzheimer Disease | 3 | 2023 | 8038 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 3 | 2022 | 4463 | 0.090 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 1340 | 0.090 |
Why?
|
| Osteoporosis | 3 | 2014 | 1579 | 0.090 |
Why?
|
| Depression | 5 | 2008 | 7759 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 1434 | 0.090 |
Why?
|
| Lipase | 2 | 2022 | 314 | 0.080 |
Why?
|
| Ambulatory Care | 4 | 2021 | 2708 | 0.080 |
Why?
|
| Receptors, Cannabinoid | 1 | 2009 | 44 | 0.080 |
Why?
|
| Aorta, Thoracic | 2 | 2012 | 1084 | 0.080 |
Why?
|
| Receptors, Melatonin | 1 | 2008 | 31 | 0.080 |
Why?
|
| Gene Regulatory Networks | 2 | 2014 | 1707 | 0.080 |
Why?
|
| Sample Size | 3 | 2021 | 845 | 0.080 |
Why?
|
| Nutritional Physiological Phenomena | 3 | 2008 | 370 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2010 | 326 | 0.080 |
Why?
|
| Computer Simulation | 3 | 2019 | 6194 | 0.080 |
Why?
|
| Osteocalcin | 1 | 2009 | 273 | 0.080 |
Why?
|
| Hip | 1 | 2010 | 257 | 0.080 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2011 | 1344 | 0.080 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 327 | 0.080 |
Why?
|
| Community-Institutional Relations | 1 | 2010 | 204 | 0.080 |
Why?
|
| Arteriosclerosis | 2 | 2005 | 1092 | 0.080 |
Why?
|
| Actinin | 2 | 1986 | 160 | 0.080 |
Why?
|
| Medicine | 2 | 2009 | 946 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2504 | 0.080 |
Why?
|
| Heart Conduction System | 1 | 2014 | 1047 | 0.080 |
Why?
|
| Communication | 3 | 2024 | 3750 | 0.080 |
Why?
|
| Amidohydrolases | 1 | 2009 | 169 | 0.080 |
Why?
|
| Social Class | 4 | 2020 | 1997 | 0.080 |
Why?
|
| Interleukin-18 | 1 | 2009 | 249 | 0.080 |
Why?
|
| Dietary Proteins | 1 | 2013 | 963 | 0.080 |
Why?
|
| Intermittent Claudication | 1 | 2010 | 309 | 0.080 |
Why?
|
| Dietary Fiber | 3 | 2006 | 760 | 0.080 |
Why?
|
| Factor VIII | 1 | 2010 | 347 | 0.080 |
Why?
|
| Gene Dosage | 2 | 2010 | 1252 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 3 | 2014 | 4805 | 0.080 |
Why?
|
| Patients | 2 | 2009 | 900 | 0.080 |
Why?
|
| Environment | 2 | 2011 | 1123 | 0.080 |
Why?
|
| Viral Load | 3 | 2012 | 3300 | 0.070 |
Why?
|
| Algorithms | 7 | 2021 | 13882 | 0.070 |
Why?
|
| Sensitivity and Specificity | 6 | 2021 | 14723 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2021 | 2861 | 0.070 |
Why?
|
| Professional Practice | 1 | 2009 | 326 | 0.070 |
Why?
|
| Dinoprost | 1 | 2007 | 138 | 0.070 |
Why?
|
| Privacy | 1 | 2009 | 238 | 0.070 |
Why?
|
| Zinc | 1 | 2011 | 684 | 0.070 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2010 | 550 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2005 | 1677 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 2010 | 867 | 0.070 |
Why?
|
| Endothelial Cells | 2 | 2024 | 3486 | 0.070 |
Why?
|
| Arginine | 1 | 2010 | 944 | 0.070 |
Why?
|
| Adipose Tissue, White | 1 | 2009 | 351 | 0.070 |
Why?
|
| Anti-HIV Agents | 4 | 2012 | 4255 | 0.070 |
Why?
|
| Motor Activity | 3 | 2012 | 2715 | 0.070 |
Why?
|
| Alcohol Drinking | 6 | 2013 | 3966 | 0.070 |
Why?
|
| Telephone | 1 | 2010 | 617 | 0.070 |
Why?
|
| Probability | 3 | 2013 | 2506 | 0.070 |
Why?
|
| Phorbols | 1 | 1986 | 43 | 0.070 |
Why?
|
| Models, Psychological | 1 | 2011 | 811 | 0.070 |
Why?
|
| Hyperemia | 1 | 2008 | 225 | 0.070 |
Why?
|
| Urban Population | 2 | 2012 | 2022 | 0.070 |
Why?
|
| Receptors, Immunologic | 2 | 2022 | 1423 | 0.070 |
Why?
|
| Informatics | 1 | 2006 | 72 | 0.070 |
Why?
|
| Iron | 2 | 2005 | 1774 | 0.070 |
Why?
|
| Baltimore | 2 | 2004 | 231 | 0.070 |
Why?
|
| Diet Surveys | 5 | 2012 | 1173 | 0.070 |
Why?
|
| Ghrelin | 1 | 2008 | 266 | 0.070 |
Why?
|
| Ischemic Attack, Transient | 1 | 2012 | 935 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2005 | 1159 | 0.070 |
Why?
|
| Brachial Artery | 1 | 2008 | 369 | 0.070 |
Why?
|
| Vitamin K | 1 | 2008 | 295 | 0.070 |
Why?
|
| Sodium | 3 | 2006 | 1622 | 0.070 |
Why?
|
| Serum Albumin | 1 | 2009 | 675 | 0.070 |
Why?
|
| Bipolar Disorder | 1 | 2023 | 5027 | 0.070 |
Why?
|
| Membrane Proteins | 4 | 2022 | 7882 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 7282 | 0.070 |
Why?
|
| Chromans | 1 | 2005 | 122 | 0.070 |
Why?
|
| Cognition | 2 | 2015 | 6770 | 0.070 |
Why?
|
| Molecular Weight | 3 | 2016 | 2255 | 0.070 |
Why?
|
| Homeodomain Proteins | 4 | 2023 | 2418 | 0.070 |
Why?
|
| Tomography, Spiral Computed | 1 | 2007 | 280 | 0.070 |
Why?
|
| Mitochondria | 1 | 2018 | 3514 | 0.070 |
Why?
|
| Models, Biological | 7 | 2013 | 9584 | 0.070 |
Why?
|
| Lisinopril | 1 | 2005 | 54 | 0.070 |
Why?
|
| Body Constitution | 4 | 2004 | 278 | 0.060 |
Why?
|
| Administration, Oral | 3 | 2009 | 3914 | 0.060 |
Why?
|
| Fruit | 2 | 2009 | 1142 | 0.060 |
Why?
|
| Drug Prescriptions | 2 | 2005 | 1637 | 0.060 |
Why?
|
| Pharmacogenetics | 1 | 2009 | 674 | 0.060 |
Why?
|
| Brain Ischemia | 2 | 2011 | 3265 | 0.060 |
Why?
|
| Iodide Peroxidase | 1 | 2007 | 293 | 0.060 |
Why?
|
| Atenolol | 1 | 2005 | 100 | 0.060 |
Why?
|
| Hydrochlorothiazide | 1 | 2005 | 98 | 0.060 |
Why?
|
| Animals | 14 | 2019 | 168768 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1986 | 821 | 0.060 |
Why?
|
| Retreatment | 1 | 2006 | 610 | 0.060 |
Why?
|
| Sickness Impact Profile | 1 | 2006 | 302 | 0.060 |
Why?
|
| England | 2 | 2019 | 522 | 0.060 |
Why?
|
| Natriuresis | 1 | 2004 | 124 | 0.060 |
Why?
|
| Genetics, Population | 3 | 2021 | 934 | 0.060 |
Why?
|
| Ventricular Function, Left | 2 | 2011 | 3666 | 0.060 |
Why?
|
| Quality of Life | 1 | 2006 | 12802 | 0.060 |
Why?
|
| Health Status | 4 | 2018 | 4034 | 0.060 |
Why?
|
| Adipocytes | 2 | 2024 | 1185 | 0.060 |
Why?
|
| Fractures, Ununited | 1 | 2006 | 165 | 0.060 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2004 | 857 | 0.060 |
Why?
|
| Nursing Assessment | 1 | 2004 | 107 | 0.060 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2007 | 434 | 0.060 |
Why?
|
| Prostatic Neoplasms | 2 | 1998 | 11126 | 0.060 |
Why?
|
| Atrial Fibrillation | 3 | 2014 | 5035 | 0.060 |
Why?
|
| Air Pollution | 1 | 2017 | 2286 | 0.060 |
Why?
|
| Reproducibility of Results | 6 | 2016 | 19905 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 6896 | 0.060 |
Why?
|
| Femoral Fractures | 1 | 2007 | 376 | 0.060 |
Why?
|
| Exercise Tolerance | 1 | 2008 | 768 | 0.060 |
Why?
|
| Trans Fatty Acids | 1 | 2005 | 153 | 0.060 |
Why?
|
| Air Pollutants | 1 | 2017 | 2816 | 0.060 |
Why?
|
| Puberty | 1 | 2007 | 490 | 0.060 |
Why?
|
| Child | 12 | 2024 | 77709 | 0.060 |
Why?
|
| Academic Medical Centers | 2 | 2005 | 2760 | 0.060 |
Why?
|
| Sex Distribution | 3 | 2018 | 2297 | 0.060 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 1 | 2023 | 26 | 0.060 |
Why?
|
| Vasodilation | 1 | 2008 | 944 | 0.060 |
Why?
|
| Renin | 3 | 2010 | 642 | 0.060 |
Why?
|
| Kidney | 4 | 2022 | 7184 | 0.060 |
Why?
|
| Enteroendocrine Cells | 1 | 2024 | 65 | 0.060 |
Why?
|
| Insulysin | 1 | 2003 | 50 | 0.060 |
Why?
|
| Cystatin C | 3 | 2010 | 250 | 0.060 |
Why?
|
| Advance Care Planning | 1 | 2011 | 662 | 0.060 |
Why?
|
| Ventricular Remodeling | 1 | 2011 | 1223 | 0.060 |
Why?
|
| KCNQ1 Potassium Channel | 2 | 2016 | 104 | 0.060 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2012 | 1164 | 0.060 |
Why?
|
| Receptors, Lipoprotein | 1 | 2003 | 81 | 0.060 |
Why?
|
| Anti-Retroviral Agents | 2 | 2018 | 1714 | 0.060 |
Why?
|
| Population Surveillance | 2 | 2011 | 2616 | 0.060 |
Why?
|
| Registries | 6 | 2013 | 8091 | 0.060 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2004 | 364 | 0.060 |
Why?
|
| Likelihood Functions | 2 | 2016 | 1005 | 0.060 |
Why?
|
| Finland | 2 | 2017 | 602 | 0.060 |
Why?
|
| Tibial Fractures | 1 | 2006 | 269 | 0.060 |
Why?
|
| Vascular Diseases | 1 | 2011 | 1161 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2005 | 460 | 0.060 |
Why?
|
| Cerebral Hemorrhage | 1 | 2014 | 2647 | 0.050 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2016 | 2560 | 0.050 |
Why?
|
| Endothelium | 1 | 2005 | 778 | 0.050 |
Why?
|
| Syndrome | 2 | 2000 | 3252 | 0.050 |
Why?
|
| Perception | 1 | 2009 | 1198 | 0.050 |
Why?
|
| Ferritins | 2 | 2022 | 590 | 0.050 |
Why?
|
| Alanine | 2 | 2003 | 572 | 0.050 |
Why?
|
| Fats | 1 | 2003 | 102 | 0.050 |
Why?
|
| Abdomen | 3 | 2020 | 1118 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 2 | 2012 | 934 | 0.050 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2005 | 451 | 0.050 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2005 | 336 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 4 | 2008 | 5867 | 0.050 |
Why?
|
| Caffeine | 2 | 2007 | 699 | 0.050 |
Why?
|
| Thiazolidinediones | 1 | 2005 | 476 | 0.050 |
Why?
|
| DNA | 3 | 2013 | 7294 | 0.050 |
Why?
|
| Treatment Outcome | 9 | 2022 | 63107 | 0.050 |
Why?
|
| Gene Expression Profiling | 5 | 2021 | 9445 | 0.050 |
Why?
|
| Drug Utilization Review | 1 | 2003 | 245 | 0.050 |
Why?
|
| Kidney Glomerulus | 1 | 2005 | 697 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 1862 | 0.050 |
Why?
|
| Quality of Health Care | 3 | 2006 | 4369 | 0.050 |
Why?
|
| Mucin-5B | 1 | 2022 | 141 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2004 | 871 | 0.050 |
Why?
|
| Education, Continuing | 1 | 2002 | 112 | 0.050 |
Why?
|
| Health Services Research | 3 | 2004 | 1836 | 0.050 |
Why?
|
| Apolipoproteins C | 1 | 2001 | 59 | 0.050 |
Why?
|
| Prostatitis | 1 | 2002 | 102 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 2 | 2013 | 147 | 0.050 |
Why?
|
| Antidepressive Agents | 2 | 2004 | 2838 | 0.050 |
Why?
|
| Pregnancy | 4 | 2023 | 29144 | 0.050 |
Why?
|
| Lactase | 1 | 2021 | 69 | 0.050 |
Why?
|
| Survival Analysis | 4 | 2010 | 10252 | 0.050 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2010 | 1872 | 0.050 |
Why?
|
| Blood Sedimentation | 1 | 2022 | 231 | 0.050 |
Why?
|
| Goals | 1 | 2006 | 707 | 0.050 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2006 | 738 | 0.050 |
Why?
|
| RNA-Binding Proteins | 3 | 2016 | 1903 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2020 | 2917 | 0.050 |
Why?
|
| Hyperaldosteronism | 1 | 2004 | 240 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 2021 | 183 | 0.050 |
Why?
|
| Pharmacists | 1 | 2003 | 248 | 0.050 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 4583 | 0.050 |
Why?
|
| Cost of Illness | 2 | 2008 | 1860 | 0.050 |
Why?
|
| Family Practice | 1 | 2004 | 516 | 0.050 |
Why?
|
| Lysophospholipase | 1 | 2020 | 63 | 0.050 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2020 | 55 | 0.050 |
Why?
|
| Kynurenine | 1 | 2021 | 139 | 0.050 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2021 | 106 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2021 | 7730 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 1986 | 1158 | 0.050 |
Why?
|
| Organ Size | 3 | 2012 | 2251 | 0.050 |
Why?
|
| Population Density | 1 | 2021 | 196 | 0.050 |
Why?
|
| Isoelectric Focusing | 1 | 2000 | 181 | 0.050 |
Why?
|
| Hospitals, General | 2 | 2020 | 749 | 0.050 |
Why?
|
| Telomere | 1 | 2006 | 910 | 0.050 |
Why?
|
| Fractures, Bone | 1 | 2012 | 1947 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8385 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2012 | 2029 | 0.040 |
Why?
|
| Blood Flow Velocity | 3 | 2009 | 1423 | 0.040 |
Why?
|
| Attitude of Health Personnel | 2 | 2004 | 3841 | 0.040 |
Why?
|
| Radiography | 4 | 2014 | 7023 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2011 | 3922 | 0.040 |
Why?
|
| Research Design | 2 | 2016 | 5984 | 0.040 |
Why?
|
| Community Health Centers | 1 | 2003 | 430 | 0.040 |
Why?
|
| Treatment Refusal | 1 | 2003 | 421 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 2007 | 1257 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 3873 | 0.040 |
Why?
|
| Hypolipidemic Agents | 2 | 2005 | 604 | 0.040 |
Why?
|
| Environmental Exposure | 2 | 2014 | 4232 | 0.040 |
Why?
|
| Eating | 2 | 2023 | 1536 | 0.040 |
Why?
|
| Indians, North American | 2 | 2013 | 355 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2022 | 426 | 0.040 |
Why?
|
| Blood Viscosity | 1 | 2000 | 124 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2021 | 279 | 0.040 |
Why?
|
| Mortality | 2 | 2009 | 2864 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2002 | 802 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2012 | 6539 | 0.040 |
Why?
|
| Penetrance | 1 | 2021 | 381 | 0.040 |
Why?
|
| Cytokines | 1 | 2014 | 7323 | 0.040 |
Why?
|
| Lipoproteins, VLDL | 1 | 2000 | 201 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2005 | 1366 | 0.040 |
Why?
|
| Gene Expression | 3 | 2021 | 7798 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2005 | 1516 | 0.040 |
Why?
|
| Specialization | 1 | 2004 | 776 | 0.040 |
Why?
|
| Fibrinolysis | 1 | 2000 | 322 | 0.040 |
Why?
|
| Chromosomes, Human, X | 1 | 2020 | 296 | 0.040 |
Why?
|
| Medical Staff, Hospital | 1 | 2003 | 601 | 0.040 |
Why?
|
| Interpersonal Relations | 1 | 2006 | 1425 | 0.040 |
Why?
|
| Bangladesh | 1 | 2020 | 687 | 0.040 |
Why?
|
| rho-Associated Kinases | 1 | 2020 | 279 | 0.040 |
Why?
|
| Vitamin B 12 | 1 | 2001 | 527 | 0.040 |
Why?
|
| Coffee | 1 | 1983 | 578 | 0.040 |
Why?
|
| Kidney Function Tests | 2 | 2010 | 683 | 0.040 |
Why?
|
| Cystatins | 2 | 2008 | 55 | 0.040 |
Why?
|
| Leukocytes | 1 | 2006 | 2045 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2020 | 315 | 0.040 |
Why?
|
| Quality Control | 1 | 2021 | 841 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2001 | 676 | 0.040 |
Why?
|
| Butter | 1 | 2017 | 22 | 0.040 |
Why?
|
| Heterozygote | 2 | 2021 | 2804 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2022 | 1588 | 0.040 |
Why?
|
| Decision Making | 1 | 2012 | 3888 | 0.040 |
Why?
|
| Nitrogen Oxides | 1 | 2017 | 129 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2011 | 9955 | 0.040 |
Why?
|
| Cheese | 1 | 2017 | 38 | 0.040 |
Why?
|
| Prehypertension | 1 | 2018 | 61 | 0.040 |
Why?
|
| Osmolar Concentration | 2 | 2012 | 683 | 0.040 |
Why?
|
| Health Resources | 1 | 2004 | 911 | 0.040 |
Why?
|
| Parents | 1 | 2011 | 3405 | 0.040 |
Why?
|
| Age Distribution | 2 | 2018 | 2902 | 0.040 |
Why?
|
| Stem Cells | 1 | 2010 | 3567 | 0.040 |
Why?
|
| Nurses | 2 | 2004 | 2462 | 0.040 |
Why?
|
| Drug Utilization | 1 | 2003 | 1183 | 0.040 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2007 | 1462 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2021 | 1264 | 0.040 |
Why?
|
| Sulfates | 1 | 2017 | 390 | 0.040 |
Why?
|
| China | 2 | 2013 | 2245 | 0.040 |
Why?
|
| Coronary Vessels | 1 | 2008 | 3107 | 0.040 |
Why?
|
| Echocardiography | 2 | 2011 | 5099 | 0.040 |
Why?
|
| Statistics as Topic | 2 | 2006 | 2373 | 0.040 |
Why?
|
| Epidemiologic Factors | 1 | 1996 | 36 | 0.040 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2016 | 44 | 0.040 |
Why?
|
| Health Education | 1 | 2003 | 1056 | 0.040 |
Why?
|
| Absorptiometry, Photon | 1 | 2022 | 1725 | 0.030 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2016 | 49 | 0.030 |
Why?
|
| Soot | 1 | 2017 | 232 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2016 | 53 | 0.030 |
Why?
|
| Family | 2 | 2004 | 3147 | 0.030 |
Why?
|
| Neoplasm Proteins | 2 | 2016 | 3707 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2010 | 2850 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2022 | 1532 | 0.030 |
Why?
|
| Child, Preschool | 4 | 2017 | 41005 | 0.030 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2016 | 91 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2017 | 373 | 0.030 |
Why?
|
| tRNA Methyltransferases | 1 | 2016 | 53 | 0.030 |
Why?
|
| Sodium-Glucose Transporter 1 | 1 | 2016 | 112 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2012 | 20130 | 0.030 |
Why?
|
| Community Health Services | 2 | 2011 | 650 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2007 | 2575 | 0.030 |
Why?
|
| Decision Support Techniques | 2 | 2019 | 1956 | 0.030 |
Why?
|
| Receptors, Somatostatin | 1 | 2016 | 129 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2008 | 3747 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2016 | 194 | 0.030 |
Why?
|
| LDL-Receptor Related Protein-Associated Protein | 1 | 2014 | 17 | 0.030 |
Why?
|
| Colon | 1 | 2023 | 1772 | 0.030 |
Why?
|
| Inpatients | 1 | 2007 | 2518 | 0.030 |
Why?
|
| Hepacivirus | 1 | 2022 | 1379 | 0.030 |
Why?
|
| Survival Rate | 3 | 2018 | 12788 | 0.030 |
Why?
|
| CpG Islands | 1 | 2019 | 1170 | 0.030 |
Why?
|
| Demography | 2 | 2013 | 1655 | 0.030 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2016 | 186 | 0.030 |
Why?
|
| Infant | 4 | 2022 | 35134 | 0.030 |
Why?
|
| Receptors, Glucagon | 1 | 2015 | 92 | 0.030 |
Why?
|
| Antiviral Agents | 2 | 2022 | 2987 | 0.030 |
Why?
|
| Folic Acid | 1 | 2001 | 1300 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 551 | 0.030 |
Why?
|
| Acute Disease | 2 | 2009 | 7147 | 0.030 |
Why?
|
| Immunoassay | 1 | 1998 | 752 | 0.030 |
Why?
|
| Cause of Death | 2 | 2016 | 3582 | 0.030 |
Why?
|
| Propensity Score | 1 | 2021 | 1781 | 0.030 |
Why?
|
| Ozone | 1 | 2017 | 469 | 0.030 |
Why?
|
| Lung Volume Measurements | 1 | 2015 | 378 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 2960 | 0.030 |
Why?
|
| Binding Sites | 2 | 2015 | 6111 | 0.030 |
Why?
|
| Anticholesteremic Agents | 1 | 2001 | 979 | 0.030 |
Why?
|
| Housing | 2 | 2017 | 664 | 0.030 |
Why?
|
| Hypertriglyceridemia | 2 | 2007 | 293 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2023 | 2073 | 0.030 |
Why?
|
| Brain | 3 | 2012 | 26388 | 0.030 |
Why?
|
| Residence Characteristics | 2 | 2017 | 2050 | 0.030 |
Why?
|
| Heart Ventricles | 2 | 2004 | 3817 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2018 | 633 | 0.030 |
Why?
|
| Alpha-Globulins | 1 | 2013 | 29 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2016 | 13035 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2013 | 94 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2182 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2013 | 118 | 0.030 |
Why?
|
| Mucin-3 | 1 | 2012 | 6 | 0.030 |
Why?
|
| Menopause | 3 | 2006 | 1626 | 0.030 |
Why?
|
| Proteins | 2 | 2010 | 6100 | 0.030 |
Why?
|
| Rats, Inbred Strains | 1 | 2014 | 2186 | 0.030 |
Why?
|
| Peripheral Arterial Disease | 1 | 2024 | 1188 | 0.030 |
Why?
|
| Vehicle Emissions | 1 | 2017 | 665 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 705 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 894 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 944 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2016 | 794 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2020 | 4010 | 0.030 |
Why?
|
| Treatment Failure | 2 | 2010 | 2618 | 0.030 |
Why?
|
| Pregnancy Outcome | 2 | 2021 | 2795 | 0.030 |
Why?
|
| Cell Line | 3 | 2013 | 16000 | 0.030 |
Why?
|
| Chromatin | 1 | 2024 | 2933 | 0.030 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2013 | 168 | 0.030 |
Why?
|
| Counseling | 1 | 2000 | 1523 | 0.030 |
Why?
|
| ARNTL Transcription Factors | 1 | 2012 | 99 | 0.030 |
Why?
|
| TRPM Cation Channels | 1 | 2013 | 140 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2013 | 10943 | 0.030 |
Why?
|
| Social Marketing | 1 | 2011 | 52 | 0.030 |
Why?
|
| Random Allocation | 1 | 1996 | 2428 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2916 | 0.030 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 159 | 0.030 |
Why?
|
| Pakistan | 1 | 2012 | 295 | 0.030 |
Why?
|
| Alkylating Agents | 1 | 1992 | 139 | 0.030 |
Why?
|
| Diet Records | 1 | 2013 | 425 | 0.030 |
Why?
|
| Vegetables | 2 | 2009 | 1182 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 2014 | 640 | 0.020 |
Why?
|
| Environmental Monitoring | 1 | 2017 | 1414 | 0.020 |
Why?
|
| Mexican Americans | 1 | 2012 | 165 | 0.020 |
Why?
|
| Mathematical Computing | 1 | 2011 | 147 | 0.020 |
Why?
|
| Exercise Test | 1 | 2018 | 2073 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2010 | 47 | 0.020 |
Why?
|
| Guidelines as Topic | 2 | 2007 | 1405 | 0.020 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2010 | 73 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2014 | 638 | 0.020 |
Why?
|
| Vitamins | 2 | 2009 | 1623 | 0.020 |
Why?
|
| Length of Stay | 1 | 2004 | 6311 | 0.020 |
Why?
|
| Bacteria | 1 | 2021 | 2115 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2015 | 1745 | 0.020 |
Why?
|
| Tobacco Use Disorder | 1 | 2016 | 688 | 0.020 |
Why?
|
| Mutation, Missense | 2 | 2011 | 2566 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2020 | 5451 | 0.020 |
Why?
|
| Directive Counseling | 1 | 2011 | 166 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5077 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2017 | 1167 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2011 | 328 | 0.020 |
Why?
|
| Models, Cardiovascular | 2 | 2008 | 996 | 0.020 |
Why?
|
| Macular Degeneration | 1 | 2017 | 980 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2012 | 320 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1983 | 2249 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3508 | 0.020 |
Why?
|
| Integrin beta Chains | 1 | 2010 | 121 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2013 | 649 | 0.020 |
Why?
|
| Mental Health Services | 1 | 2021 | 1644 | 0.020 |
Why?
|
| Fatty Acid Desaturases | 1 | 2010 | 102 | 0.020 |
Why?
|
| Micronutrients | 1 | 2012 | 375 | 0.020 |
Why?
|
| Connecticut | 4 | 1983 | 366 | 0.020 |
Why?
|
| Organizations, Nonprofit | 1 | 2010 | 104 | 0.020 |
Why?
|
| Reminder Systems | 1 | 2012 | 371 | 0.020 |
Why?
|
| Skinfold Thickness | 2 | 1971 | 162 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2007 | 4639 | 0.020 |
Why?
|
| Endonucleases | 1 | 2012 | 380 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2015 | 1077 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 2569 | 0.020 |
Why?
|
| Incretins | 1 | 2010 | 88 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 867 | 0.020 |
Why?
|
| Proteomics | 1 | 2022 | 3638 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 3617 | 0.020 |
Why?
|
| Software | 1 | 2003 | 4441 | 0.020 |
Why?
|
| Appointments and Schedules | 1 | 2012 | 417 | 0.020 |
Why?
|
| Metagenomics | 1 | 2012 | 428 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2021 | 3589 | 0.020 |
Why?
|
| Cardiac Output | 1 | 2011 | 854 | 0.020 |
Why?
|
| Genes | 1 | 2012 | 1893 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2011 | 812 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2009 | 332 | 0.020 |
Why?
|
| Solubility | 1 | 2009 | 1088 | 0.020 |
Why?
|
| Physicians | 2 | 2003 | 4567 | 0.020 |
Why?
|
| Hormones | 1 | 2012 | 889 | 0.020 |
Why?
|
| Femur | 1 | 2014 | 1297 | 0.020 |
Why?
|
| Mutation | 3 | 2023 | 29786 | 0.020 |
Why?
|
| Critical Illness | 1 | 2021 | 2670 | 0.020 |
Why?
|
| Aortic Aneurysm | 1 | 2012 | 644 | 0.020 |
Why?
|
| Mice | 4 | 2019 | 81201 | 0.020 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1992 | 547 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2001 | 5023 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 1115 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2006 | 6882 | 0.020 |
Why?
|
| Denmark | 1 | 2010 | 738 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 4185 | 0.020 |
Why?
|
| Medical Audit | 1 | 2009 | 467 | 0.020 |
Why?
|
| Electrocardiography | 2 | 2014 | 6442 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2014 | 1539 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2011 | 784 | 0.020 |
Why?
|
| Community-Based Participatory Research | 1 | 2009 | 214 | 0.020 |
Why?
|
| Spine | 1 | 2014 | 1144 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2009 | 980 | 0.020 |
Why?
|
| Blood Proteins | 1 | 2012 | 1124 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2022 | 4925 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2020 | 5316 | 0.020 |
Why?
|
| Sucrose | 1 | 2007 | 164 | 0.020 |
Why?
|
| Veterans | 1 | 2020 | 2519 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 1152 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 3702 | 0.020 |
Why?
|
| Blood Circulation | 1 | 2007 | 251 | 0.020 |
Why?
|
| Osteoprotegerin | 1 | 2007 | 176 | 0.020 |
Why?
|
| Vinculin | 1 | 1986 | 62 | 0.020 |
Why?
|
| Particulate Matter | 1 | 2017 | 2529 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2012 | 1335 | 0.020 |
Why?
|
| Epidemiologic Methods | 2 | 2009 | 1364 | 0.020 |
Why?
|
| Manometry | 1 | 2008 | 445 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2016 | 9647 | 0.020 |
Why?
|
| Thorax | 1 | 2009 | 547 | 0.020 |
Why?
|
| Transfection | 1 | 2014 | 5895 | 0.020 |
Why?
|
| Rhodamines | 1 | 1986 | 183 | 0.020 |
Why?
|
| Albumins | 1 | 2008 | 568 | 0.020 |
Why?
|
| Vulvar Neoplasms | 2 | 1958 | 272 | 0.020 |
Why?
|
| Microinjections | 1 | 1986 | 327 | 0.020 |
Why?
|
| HIV | 1 | 2012 | 1604 | 0.020 |
Why?
|
| Calcium | 2 | 2009 | 5755 | 0.020 |
Why?
|
| Femoral Artery | 1 | 2009 | 845 | 0.020 |
Why?
|
| Internationality | 1 | 2010 | 1002 | 0.020 |
Why?
|
| Wilms Tumor | 1 | 1988 | 373 | 0.020 |
Why?
|
| Glycerides | 1 | 1964 | 71 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2009 | 950 | 0.020 |
Why?
|
| Siblings | 1 | 2009 | 854 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 4222 | 0.020 |
Why?
|
| Cholecalciferol | 1 | 2009 | 535 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 1572 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 1976 | 1917 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2013 | 2499 | 0.010 |
Why?
|
| Heart | 2 | 2016 | 4464 | 0.010 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2005 | 164 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14561 | 0.010 |
Why?
|
| Chickens | 1 | 1986 | 865 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 1992 | 1415 | 0.010 |
Why?
|
| Exercise Therapy | 1 | 2011 | 904 | 0.010 |
Why?
|
| Vasculitis | 1 | 2008 | 519 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2012 | 1609 | 0.010 |
Why?
|
| Thyrotropin | 1 | 2007 | 849 | 0.010 |
Why?
|
| Emigrants and Immigrants | 1 | 2010 | 522 | 0.010 |
Why?
|
| RNA Interference | 1 | 2012 | 2890 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2013 | 2926 | 0.010 |
Why?
|
| Pinocytosis | 1 | 1983 | 65 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4208 | 0.010 |
Why?
|
| Apolipoproteins B | 1 | 2005 | 374 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2010 | 1205 | 0.010 |
Why?
|
| Morbidity | 1 | 2009 | 1768 | 0.010 |
Why?
|
| Coloring Agents | 1 | 1986 | 566 | 0.010 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2003 | 81 | 0.010 |
Why?
|
| Diuretics | 1 | 2006 | 591 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 2006 | 535 | 0.010 |
Why?
|
| Abdominal Wall | 1 | 1964 | 157 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 1793 | 0.010 |
Why?
|
| Receptors, Scavenger | 1 | 2003 | 121 | 0.010 |
Why?
|
| Hemoglobinometry | 1 | 2002 | 35 | 0.010 |
Why?
|
| Arteries | 1 | 2008 | 1119 | 0.010 |
Why?
|
| Monocytes | 1 | 2012 | 2596 | 0.010 |
Why?
|
| Reproduction | 1 | 1988 | 668 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1988 | 707 | 0.010 |
Why?
|
| Receptors, Transferrin | 1 | 2004 | 296 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 3771 | 0.010 |
Why?
|
| Forearm | 1 | 1964 | 409 | 0.010 |
Why?
|
| Myocardium | 2 | 1985 | 4772 | 0.010 |
Why?
|
| Base Sequence | 1 | 2013 | 12797 | 0.010 |
Why?
|
| Iron Overload | 1 | 2004 | 242 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1986 | 934 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2013 | 4576 | 0.010 |
Why?
|
| Proline | 1 | 2003 | 458 | 0.010 |
Why?
|
| Cells, Cultured | 3 | 2014 | 19233 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2004 | 595 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 504 | 0.010 |
Why?
|
| Medical Records | 1 | 2007 | 1413 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 1941 | 0.010 |
Why?
|
| Patient Care Planning | 1 | 2007 | 921 | 0.010 |
Why?
|
| Fishes | 1 | 2004 | 569 | 0.010 |
Why?
|
| Peptides | 1 | 2013 | 4410 | 0.010 |
Why?
|
| Minority Groups | 1 | 2008 | 1221 | 0.010 |
Why?
|
| Threonine | 1 | 2001 | 279 | 0.010 |
Why?
|
| Patient Participation | 1 | 2010 | 1457 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 1985 | 1185 | 0.010 |
Why?
|
| Ultrasonography | 2 | 2004 | 5984 | 0.010 |
Why?
|
| Bulimia | 1 | 2002 | 383 | 0.010 |
Why?
|
| Self Report | 1 | 2011 | 3553 | 0.010 |
Why?
|
| Apolipoprotein C-III | 1 | 2001 | 202 | 0.010 |
Why?
|
| Delivery of Health Care | 2 | 2014 | 5321 | 0.010 |
Why?
|
| Public Health | 1 | 2012 | 2602 | 0.010 |
Why?
|
| Health Promotion | 1 | 2011 | 2205 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1986 | 3144 | 0.010 |
Why?
|
| Diet, Reducing | 1 | 2002 | 462 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 2716 | 0.010 |
Why?
|
| Particle Size | 1 | 2003 | 1642 | 0.010 |
Why?
|
| Life Expectancy | 1 | 2005 | 1184 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1983 | 2556 | 0.010 |
Why?
|
| Lysosomes | 1 | 1983 | 893 | 0.010 |
Why?
|
| HIV Protease Inhibitors | 1 | 2000 | 430 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 1730 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2017 | 25628 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2007 | 2901 | 0.010 |
Why?
|
| Fibroblasts | 2 | 1985 | 4162 | 0.010 |
Why?
|
| Women's Health | 1 | 2007 | 2034 | 0.010 |
Why?
|
| Research | 1 | 2006 | 1999 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2005 | 1828 | 0.010 |
Why?
|
| Rats | 1 | 2014 | 24252 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1983 | 1539 | 0.010 |
Why?
|
| Osteoarthritis | 1 | 2005 | 1036 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 6366 | 0.010 |
Why?
|
| Skin | 1 | 1971 | 4372 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 5856 | 0.010 |
Why?
|
| Actins | 1 | 1985 | 2121 | 0.010 |
Why?
|
| Lead | 1 | 1982 | 852 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2008 | 2897 | 0.010 |
Why?
|
| Heart Atria | 1 | 2003 | 1356 | 0.010 |
Why?
|
| Water Supply | 1 | 1978 | 214 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 21833 | 0.010 |
Why?
|
| Carcinoma | 2 | 1958 | 2375 | 0.010 |
Why?
|
| Asbestos | 1 | 1978 | 251 | 0.010 |
Why?
|
| Thrombosis | 1 | 2010 | 2968 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 16690 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2006 | 2148 | 0.010 |
Why?
|
| Estrogens | 1 | 1982 | 1566 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2005 | 1887 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2008 | 8319 | 0.010 |
Why?
|
| Forecasting | 1 | 2004 | 2951 | 0.010 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2001 | 1203 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2008 | 12025 | 0.010 |
Why?
|
| Vaginal Neoplasms | 1 | 1954 | 106 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 6171 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1976 | 1681 | 0.010 |
Why?
|
| Chick Embryo | 2 | 1985 | 982 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2004 | 4026 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2001 | 1809 | 0.010 |
Why?
|
| Menstruation | 1 | 1954 | 302 | 0.010 |
Why?
|
| Uterine Neoplasms | 1 | 1982 | 1513 | 0.010 |
Why?
|
| Pediatrics | 1 | 1988 | 3475 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 35425 | 0.010 |
Why?
|
| Postmenopause | 1 | 2001 | 2460 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1958 | 4034 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 8642 | 0.010 |
Why?
|
| Atlantic Islands | 1 | 1971 | 3 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1988 | 4262 | 0.010 |
Why?
|
| Uterus | 1 | 1954 | 711 | 0.010 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1978 | 990 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2002 | 5388 | 0.010 |
Why?
|
| HIV-1 | 1 | 2007 | 6939 | 0.010 |
Why?
|
| Thinness | 1 | 1971 | 480 | 0.000 |
Why?
|
| Microscopy, Fluorescence | 2 | 1985 | 2700 | 0.000 |
Why?
|
| Menstruation Disturbances | 1 | 1988 | 148 | 0.000 |
Why?
|
| Kinetics | 2 | 1985 | 6476 | 0.000 |
Why?
|
| Endometriosis | 1 | 1954 | 839 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 12961 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2010 | 23404 | 0.000 |
Why?
|
| Myofibrils | 1 | 1985 | 146 | 0.000 |
Why?
|
| Amoeba | 1 | 1983 | 21 | 0.000 |
Why?
|
| Wounds and Injuries | 1 | 1976 | 2400 | 0.000 |
Why?
|
| Vesicovaginal Fistula | 1 | 1962 | 12 | 0.000 |
Why?
|
| Referral and Consultation | 1 | 1976 | 3531 | 0.000 |
Why?
|
| Ribonucleases | 1 | 1983 | 287 | 0.000 |
Why?
|
| Intracellular Membranes | 1 | 1983 | 391 | 0.000 |
Why?
|
| Urinary Calculi | 1 | 1962 | 91 | 0.000 |
Why?
|
| Membrane Fusion | 1 | 1983 | 276 | 0.000 |
Why?
|
| Urinary Bladder Diseases | 1 | 1962 | 166 | 0.000 |
Why?
|
| Urination Disorders | 1 | 1962 | 241 | 0.000 |
Why?
|
| Cytoplasmic Granules | 1 | 1983 | 610 | 0.000 |
Why?
|
| Family Characteristics | 1 | 1982 | 1000 | 0.000 |
Why?
|
| Hysterectomy | 1 | 1962 | 927 | 0.000 |
Why?
|
| Carcinoma in Situ | 1 | 1982 | 806 | 0.000 |
Why?
|
| Hypotension | 1 | 1961 | 884 | 0.000 |
Why?
|
| Protein Binding | 1 | 1985 | 9384 | 0.000 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1962 | 2020 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 1988 | 8861 | 0.000 |
Why?
|